JUN 24, 2019 09:55 PM PDT

Preventing inflammation to manage cancer

New research led by Dipak Panigrahy, MD, and Allison Gartung, PhD, of the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) suggests that traditional cancer treatments may be doing more harm than good – particularly when it comes to inflammation and new tumor growth. The study was published online in The Journal of Clinical Investigation.

"Cancer therapy is a double-edged sword, as dying cancer cells can trigger inflammation and promote the growth of microscopic cancerous cells," said Panigrahy. "Surgery, chemotherapy and radiation can all induce the body's inflammatory/immunosuppressive injury response. Even anesthetics can impair the resolution of inflammation."

The idea is that physiologic stress, which could come in any of the forms that Panigrahy mentions above, can trigger microscopic cancers to grow into new tumors. In order to prevent that, Panigrahy and colleagues thought to try blocking of the inflammatory cascade and/or accelerating the resolution of inflammation.

One method through which they tried this process was via administering a nonsteroidal anti-inflammatory drug called ketorolac before surgery; they also tired administering preoperative resolvins -- naturally occurring anti-inflammatory factors that are made by the human body. Both of these processes eliminated the spread of cancer cells in several tumor-resection models, meaning that they have potential for improving anti-inflammatory cancer treatments in the future.

Managing inflammation could help patients with cancer. Photo: Pixabay

While the researchers conducted their study on animal models, not humans, co-author Vikas P. Sukhatme, MD, ScD, and Dean of Emory University School of Medicine, says "Collectively, our findings suggest a potential paradigm shift in our approach to resectable cancers. Clinical trials are now urgently needed to validate these animal studies."

Sources: Science Daily, The Journal of Clinical Investigation

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 18, 2019
Cell & Molecular Biology
JUL 18, 2019
Efficacy of Cancer Therapeutics is Better When Muscle Mass is Normal
Scientists have determined that increasing muscle mass could be a life-saver....
JUL 18, 2019
Microbiology
JUL 18, 2019
Using Engineered Bacteria to Rapidly Evaluate Therapeutics
Scientists are using genetic tools to engineer bacteria in many ways. These new microbes are able to mimic or sense disease states......
JUL 18, 2019
Cancer
JUL 18, 2019
Children with liver cancer may not need as much chemo
Results from a phase 3 clinical trial show that children with liver cancer may not need as much chemotherapy as has been traditionally administered. The mo...
JUL 18, 2019
Cancer
JUL 18, 2019
Antioxidants make lung cancer metastasize
Two new studies report exciting discoveries regarding lung cancer cells’ capacity to metastasize. Lung cancer is the leading cause of cancer-related ...
JUL 18, 2019
Cancer
JUL 18, 2019
This Ovarian Cancer Drug Prolongs Life
Niraparib is a drug and a PARP inhibitor that targets cancer cells without harming others. PARP inhibitors keep PARP -- proteins that fix damaged DNA in ca...
JUL 18, 2019
Cancer
JUL 18, 2019
The risks of an inflammatory diet
New research published recently in Nutrients highlights the detriments that an inflammatory diet can have on increasing the risk of certain types of breast...
Loading Comments...